Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Apr;61(4):293-304.
doi: 10.1007/s00011-011-0410-x. Epub 2012 Jan 8.

Anti-arthritic activity of agnuside mediated through the down-regulation of inflammatory mediators and cytokines

Affiliations

Anti-arthritic activity of agnuside mediated through the down-regulation of inflammatory mediators and cytokines

Anjali Pandey et al. Inflamm Res. 2012 Apr.

Abstract

Objective and design: The purpose of this study was to elucidate the probable mechanism for the anti-arthritic activity of agnuside (AGN), a compound isolated from the leaf extract of Vitex negundo.

Methodology: The anti-inflammatory activity of AGN within a dose range of 1.56-12.50 mg/kg in normal and adrenalectomized rats was evaluated against different inflammagens. An array of pro-inflammatory mediators (PGE(2) and LTB(4)) and T-cell-mediated cytokines (IL-2, TNF-α, IFN-γ, IL-4, IL-10, IL-17) was assayed using flow cytometry, in arthritic paw tissue homogenate and splenocytes of treated animals.

Results: Significant anti-arthritic activity was observed in the polyarthritis test in rats and this was associated with significant suppression of inflammatory mediators and T-cell-mediated cytokines (Th1/Th2). The anti-inflammatory activity in adrenalectomized rats confirmed that the effect of AGN is not mediated by the pituitary-adrenal axis. AGN also showed inhibition of vascular permeability and leukocyte migration in vivo.

Conclusion: The study suggests the possible development of AGN as a therapeutic agent in the treatment of arthritis by the modulation of the host immune response.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Pharmacol Methods. 1982 Aug;8(1):33-7 - PubMed
    1. J Ethnopharmacol. 2005 Jun 3;99(2):185-92 - PubMed
    1. J Infect Dis. 1999 Jan;179(1):279-82 - PubMed
    1. Rheumatology (Oxford). 1999 Mar;38(3):214-20 - PubMed
    1. Vaccine. 2007 Jun 6;25(23):4586-94 - PubMed

MeSH terms

LinkOut - more resources